Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Multi-center, multiple-dose, randomized, double-blind, three-arm, placebo-controlled study of
fixed-dose repeated oral dosing for 30 days of 10 mg and 30 mg MP-101 and placebo in obese
subjects.